These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 18512901)

  • 1. Conformationally constrained analogues of N-(piperidinyl)-5-(4-chlorophenyl)-1-(2,4- dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716): design, synthesis, computational analysis, and biological evaluations.
    Zhang Y; Burgess JP; Brackeen M; Gilliam A; Mascarella SW; Page K; Seltzman HH; Thomas BF
    J Med Chem; 2008 Jun; 51(12):3526-39. PubMed ID: 18512901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity relationships of amide and hydrazide analogues of the cannabinoid CB(1) receptor antagonist N-(piperidinyl)- 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716).
    Francisco ME; Seltzman HH; Gilliam AF; Mitchell RA; Rider SL; Pertwee RG; Stevenson LA; Thomas BF
    J Med Chem; 2002 Jun; 45(13):2708-19. PubMed ID: 12061874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tricyclic pyrazoles. 3. Synthesis, biological evaluation, and molecular modeling of analogues of the cannabinoid antagonist 8-chloro-1-(2',4'-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide.
    Murineddu G; Ruiu S; Loriga G; Manca I; Lazzari P; Reali R; Pani L; Toma L; Pinna GA
    J Med Chem; 2005 Nov; 48(23):7351-62. PubMed ID: 16279795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methoxy- and fluorine-substituted analogs of O-1302: synthesis and in vitro binding affinity for the CB1 cannabinoid receptor.
    Tobiishi S; Sasada T; Nojiri Y; Yamamoto F; Mukai T; Ishiwata K; Maeda M
    Chem Pharm Bull (Tokyo); 2007 Aug; 55(8):1213-7. PubMed ID: 17666847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of long-chain amide analogs of the cannabinoid CB1 receptor antagonist N-(piperidinyl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716) with unique binding selectivities and pharmacological activities.
    Thomas BF; Francisco ME; Seltzman HH; Thomas JB; Fix SE; Schulz AK; Gilliam AF; Pertwee RG; Stevenson LA
    Bioorg Med Chem; 2005 Sep; 13(18):5463-74. PubMed ID: 15994087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular interaction of the antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1- (2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide with the CB1 cannabinoid receptor.
    Shim JY; Welsh WJ; Cartier E; Edwards JL; Howlett AC
    J Med Chem; 2002 Mar; 45(7):1447-59. PubMed ID: 11906286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, biological evaluation, and structural studies on N1 and C5 substituted cycloalkyl analogues of the pyrazole class of CB1 and CB2 ligands.
    Krishnamurthy M; Li W; Moore BM
    Bioorg Med Chem; 2004 Jan; 12(2):393-404. PubMed ID: 14723958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tricyclic pyrazoles. 4. Synthesis and biological evaluation of analogues of the robust and selective CB2 cannabinoid ligand 1-(2',4'-dichlorophenyl)-6-methyl-N-piperidin-1-yl-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide.
    Murineddu G; Lazzari P; Ruiu S; Sanna A; Loriga G; Manca I; Falzoi M; Dessì C; Curzu MM; Chelucci G; Pani L; Pinna GA
    J Med Chem; 2006 Dec; 49(25):7502-12. PubMed ID: 17149879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biarylpyrazole inverse agonists at the cannabinoid CB1 receptor: importance of the C-3 carboxamide oxygen/lysine3.28(192) interaction.
    Hurst D; Umejiego U; Lynch D; Seltzman H; Hyatt S; Roche M; McAllister S; Fleischer D; Kapur A; Abood M; Shi S; Jones J; Lewis D; Reggio P
    J Med Chem; 2006 Oct; 49(20):5969-87. PubMed ID: 17004712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and characterization of NESS 0327: a novel putative antagonist of the CB1 cannabinoid receptor.
    Ruiu S; Pinna GA; Marchese G; Mussinu JM; Saba P; Tambaro S; Casti P; Vargiu R; Pani L
    J Pharmacol Exp Ther; 2003 Jul; 306(1):363-70. PubMed ID: 12663689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational design, synthesis and biological evaluation of new 1,5-diarylpyrazole derivatives as CB1 receptor antagonists, structurally related to rimonabant.
    Menozzi G; Fossa P; Cichero E; Spallarossa A; Ranise A; Mosti L
    Eur J Med Chem; 2008 Dec; 43(12):2627-38. PubMed ID: 18342403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists.
    Lan R; Liu Q; Fan P; Lin S; Fernando SR; McCallion D; Pertwee R; Makriyannis A
    J Med Chem; 1999 Feb; 42(4):769-76. PubMed ID: 10052983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioisosteric replacements of the pyrazole moiety of rimonabant: synthesis, biological properties, and molecular modeling investigations of thiazoles, triazoles, and imidazoles as potent and selective CB1 cannabinoid receptor antagonists.
    Lange JH; van Stuivenberg HH; Coolen HK; Adolfs TJ; McCreary AC; Keizer HG; Wals HC; Veerman W; Borst AJ; de Looff W; Verveer PC; Kruse CG
    J Med Chem; 2005 Mar; 48(6):1823-38. PubMed ID: 15771428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxadiazole-diarylpyrazole 4-carboxamides as cannabinoid CB1 receptor ligands.
    Lee SH; Seo HJ; Kim MJ; Kang SY; Song KS; Lee SH; Jung ME; Kim J; Lee J
    Bioorg Med Chem Lett; 2009 Apr; 19(7):1899-902. PubMed ID: 19269817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diaryl dihydropyrazole-3-carboxamides with significant in vivo antiobesity activity related to CB1 receptor antagonism: synthesis, biological evaluation, and molecular modeling in the homology model.
    Srivastava BK; Joharapurkar A; Raval S; Patel JZ; Soni R; Raval P; Gite A; Goswami A; Sadhwani N; Gandhi N; Patel H; Mishra B; Solanki M; Pandey B; Jain MR; Patel PR
    J Med Chem; 2007 Nov; 50(24):5951-66. PubMed ID: 17979261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facile synthesis, ex-vivo and in vitro screening of 3-sulfonamide derivative of 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid piperidin-1-ylamide (SR141716) a potent CB1 receptor antagonist.
    Kumar Srivastava B; Soni R; Patel JZ; Jha S; Shedage SA; Gandhi N; Sairam KV; Pawar V; Sadhwani N; Mitra P; Jain MR; Patel PR
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3882-6. PubMed ID: 18585913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1-Aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide: an effective scaffold for the design of either CB1 or CB2 receptor ligands.
    Piscitelli F; Ligresti A; La Regina G; Gatti V; Brizzi A; Pasquini S; Allarà M; Carai MA; Novellino E; Colombo G; Di Marzo V; Corelli F; Silvestri R
    Eur J Med Chem; 2011 Nov; 46(11):5641-53. PubMed ID: 21996466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tricyclic pyrazoles. Part 8. Synthesis, biological evaluation and modelling of tricyclic pyrazole carboxamides as potential CB2 receptor ligands with antagonist/inverse agonist properties.
    Deiana V; Gómez-Cañas M; Pazos MR; Fernández-Ruiz J; Asproni B; Cichero E; Fossa P; Muñoz E; Deligia F; Murineddu G; García-Arencibia M; Pinna GA
    Eur J Med Chem; 2016 Apr; 112():66-80. PubMed ID: 26890113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of 7-oxopyrazolo[1,5-a]pyrimidine-6-carboxamides as potent and selective CB(2) cannabinoid receptor inverse agonists.
    Aghazadeh Tabrizi M; Baraldi PG; Saponaro G; Moorman AR; Romagnoli R; Preti D; Baraldi S; Ruggiero E; Tintori C; Tuccinardi T; Vincenzi F; Borea PA; Varani K
    J Med Chem; 2013 Jun; 56(11):4482-96. PubMed ID: 23697626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of CB1 cannabinoid receptor ligands derived from the 1,5-diarylpyrazole scaffold.
    Tu G; Xiong F; Huang H; Kuang B; Li S
    J Enzyme Inhib Med Chem; 2011 Apr; 26(2):222-30. PubMed ID: 20565336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.